Prevalence and predictors of metabolic syndrome in schizophrenia patients from Assam.

ABSTRACT:

Background

Metabolic abnormalities contribute enormously to morbidity and mortality in schizophrenia.

Objectives

Our objectives were to determine the (i) prevalence of metabolic syndrome (MS); and (ii) predictors for MS in schizophrenia patients from Assam.

Materials and methods

Seventy-five schizophrenia patients were evaluated for MS. Risk factors were assessed by odds ratios (ORs) with 95% confidence intervals (CIs).

Results

Fifty-nine patients (78.7%) had a metabolic abnormality. Twenty-two patients (29.3%, 95% CI: 19.9%-40.8%) fulfilled the criteria for MS. Female gender (adjusted OR = 7.8, 95% CI: 1.7-36.4), smoking (adjusted OR = 7.9, 95% CI: 1.7-35.8), family history of chronic lifestyle disease (adjusted OR = 4.4, 95% CI: 1.3-15.2), and atypical antips

SUBMITTER: Das D 

PROVIDER: S-EPMC5547867 | biostudies-literature | 2017 Apr-Jun

REPOSITORIES: biostudies-literature